Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Cardiology Research and Practice|February 15, 2011
Adiponectin provides cardiovascular protection in metabolic syndromeYoshihisa Okamoto
Arerugi = [Allergy]|June 19, 2012
[A case of oral allergy syndrome whose symptoms were dramatically improved after rush subcutaneous injection immunotherapy with pollen extracts of birch]Yoshihisa Okamoto, Kazuyuki Kurihara
Arerugi = [Allergy]|March 18, 2015
[A case of eosinophilic esophagogastroenteritis which developed after rush oral immunotherapy for egg allergy]Yoshihisa Okamoto, Kazuyuki Kurihara
Circulation Journal : Official Journal of the Japanese Circulation Society|January 13, 2010
Inflammation in atherosclerosis: transition from theory to practicePeter Libby, Yoshihisa Okamoto, Viviane Z Rocha, et al.
Clinical Science (London, England : 1979)|February 9, 2006
Adiponectin: a key adipocytokine in metabolic syndromeYoshihisa Okamoto, Shinji Kihara, Tohru Funahashi, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|June 24, 2014
Monitoring Ara h 1, 2 and 3-sIgE and sIgG4 antibodies in peanut allergic children receiving oral rush immunotherapyAsako Nozawa, Yoshihisa Okamoto, Robert Movérare, et al.
European Journal of Pharmacology|August 4, 2011
JTT-305, an orally active calcium-sensing receptor antagonist, stimulates transient parathyroid hormone release and bone formation in ovariectomized ratsShuichi Kimura, Takashi Nakagawa, Yushi Matsuo, et al.
Hypertension (Dallas, Tex. : 1979)|October 25, 2006
Local renin angiotensin expression regulates human mesenchymal stem cell differentiation to adipocytesKenichi Matsushita, Yaojiong Wu, Yoshihisa Okamoto, et al.
Arerugi = [Allergy]|May 18, 2018
[EVALUATION OF THE EFFECTIVENESS OF SUBCUTANEOUS IMMUNOTHERAPY USING BIRCH POLLEN EXTRACT FOR POLLEN-FOOD ALLERGY SYNDROME]Shuntaro Tsumagari, Satomi Mori, Hiroko Ishizu, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|January 18, 2013
Sunitinib, a small-molecule receptor tyrosine kinase inhibitor, suppresses neointimal hyperplasia in balloon-injured rat carotid arterySo Ishii, Yoshihisa Okamoto, Harumi Katsumata, et al.
Pageof 4